Cameco
CCJ
58.00
-3.42
-5.57%
Cameco
US · CCJ
#575 by market cap
Listed 1970
58.00
-3.42
-5.57%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.67, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
Single-engine
- WEC is the largest reported line at 144.65% of revenue, across 5 reported segments.
- The next-largest line, Uranium, is a distant second at 83.67% - a sharp slowdown here would have little to offset it.
Revenue annual, last 8 years
Latest year +11.04% YoY
Margins
- Gross margin
- 27.87%
- Operating margin
- 17.84%
- Net margin
- 16.93%
Key ratios & quality
- PEG ratioi
- 1.04
- Altman Z-Scorei
- 5.67
PEG uses trailing P/E against the 3-year net income growth rate (87.54%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09B | 1.86B | 1.80B | 1.47B | 1.87B | 2.59B | 3.14B | 3.48B |
| Gross profit | 295.75M | 241.63M | 106.45M | 1.93M | 233.29M | 561.67M | 782.58M | 970.27M |
| Selling & admin expenses | 141.55M | 124.87M | 145.34M | 127.57M | 172.03M | 245.54M | 253.15M | 311.25M |
| Research & development | 1.76M | 6.06M | 3.97M | 7.17M | 12.18M | 21.04M | 36.54M | 38.47M |
| Operating profit | 72.54M | 94.28M | -40.31M | -111.20M | 15.57M | 285.05M | 511.16M | 621.26M |
| Pretax profit | 39.93M | 135.02M | -39.53M | -103.86M | 84.80M | 487.15M | 256.72M | 777.26M |
| Tax | -126.31M | 61.08M | 13.67M | -1.20M | -4.47M | 126.34M | 84.87M | 187.72M |
| Net profit | 166.24M | 73.94M | -53.20M | -102.65M | 89.26M | 360.82M | 171.84M | 589.54M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Diluted EPS | 0.42 | 0.19 | -0.13 | -0.26 | 0.22 | 0.83 | 0.39 | 1.35 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 877.02M | 614.56M | 1.20B | 845.37M | 813.77M | 619.06M |
| Gross profit | 257.09M | 170.25M | 272.80M | 301.58M | 190.14M | 122.24M |
| Selling & admin expenses | 96.44M | 67.50M | 88.50M | 122.46M | 77.00M | 60.68M |
| Research & development | -708.00K | 10.28M | 14.91M | 13.90M | 9.71M | 12.86M |
| Operating profit | 156.26M | 82.51M | 204.32M | 164.15M | 74.14M | 56.79M |
| Pretax profit | 391.97M | 15.71M | 246.43M | 162.90M | 45.93M | 54.49M |
| Tax | 71.09M | 15.87M | 47.36M | 32.15M | 20.72M | 11.78M |
| Net profit | 320.89M | -158.00K | 199.06M | 130.75M | 25.21M | 42.71M |
| Basic EPS | 1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.74 | 0.00 | 0.45 | 0.30 | 0.06 | 0.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.08B | 1.81B | 1.95B | 2.14B | 3.32B | 1.84B | 1.92B | 2.64B |
| Cash & ST investments | 1.10B | 1.06B | 943.37M | 1.33B | 2.28B | 566.81M | 600.46M | 1.21B |
| Inventory | 557.00M | 406.27M | 769.80M | 504.86M | 822.61M | 841.61M | 972.25M | 1.01B |
| Total assets | 8.02B | 7.43B | 7.58B | 7.52B | 8.63B | 9.93B | 9.91B | 10.30B |
| Total current liabilities | 875.88M | 277.41M | 303.78M | 413.74M | 560.84M | 1.19B | 1.19B | 1.07B |
| Short-term debt | 499.60M | -- | -- | -- | -- | 499.82M | 285.71M | -- |
| Long-term debt | 996.07M | 996.72M | 995.54M | 996.25M | 997.00M | 1.28B | 995.58M | 996.35M |
| Total liabilities | 3,025,044,000.00 | 2,432,285,000.00 | 2,622,270,000.00 | 2,671,776,000.00 | 2,796,728,000.00 | 3,839,748,000.00 | 3,542,674,000.00 | 3,397,904,000.00 |
| Total equity | 4.99B | 4.99B | 4.96B | 4.85B | 5.84B | 6.09B | 6.36B | 6.90B |
| Retained earnings | 2.79B | 2.83B | 2.74B | 2.64B | 2.70B | 2.98B | 3.10B | 3.61B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 1.80B | 1.89B | 2.64B | 2.24B | 2.44B | 2.28B |
| Cash & ST investments | 716.29M | 778.65M | 1.21B | 1.11B | 1.11B | 859.82M |
| Inventory | 734.16M | 899.96M | 1.01B | 899.34M | 946.83M | 1.06B |
| Total assets | 9.58B | 9.74B | 10.30B | 10.11B | 10.30B | 10.38B |
| Total current liabilities | 608.89M | 631.45M | 1.07B | 727.03M | 798.47M | 893.37M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 995.97M | 996.16M | 996.35M | 996.55M | 996.75M | 996.95M |
| Total liabilities | 2,840,073,000.00 | 2,958,804,000.00 | 3,397,904,000.00 | 3,040,940,000.00 | 3,161,769,000.00 | 3,143,710,000.00 |
| Total equity | 6.74B | 6.78B | 6.90B | 7.06B | 7.13B | 7.23B |
| Retained earnings | 3.49B | 3.49B | 3.61B | 3.74B | 3.76B | 3.81B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 667.52M | 527.02M | 56.89M | 458.29M | 304.61M | 688.14M | 905.29M | 1.41B |
| Depreciation & amortization | 327.97M | 275.75M | 208.66M | 190.42M | 177.38M | 220.32M | 280.70M | 293.09M |
| Free cash flow | 612.15M | 451.81M | -20.57M | 359.50M | 161.16M | 534.51M | 693.65M | 1.08B |
| Dividends paid | -71.22M | -31.61M | -31.64M | -31.84M | -51.90M | -52.08M | -69.64M | -104.48M |
| Stock buybacks / issuance | 0 | 81.00K | 5.38M | 26.77M | 962.92M | 27.54M | 16.66M | 2.17M |
| Ending cash balance | 711.53M | 1.06B | 918.38M | 1.25B | 1.14B | 566.81M | 600.46M | 1.11B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 465.20M | 155.72M | 677.33M | -22.28M | 131.03M | 3.29M |
| Depreciation & amortization | 86.47M | 59.11M | 86.91M | 67.10M | 72.16M | 64.18M |
| Free cash flow | 390.28M | 63.21M | 568.19M | -100.02M | 24.54M | -133.99M |
| Dividends paid | 0 | 0 | -104.48M | 0 | 0 | 0 |
| Stock buybacks / issuance | 1.02M | 300.00K | 773.00K | 1.15M | 0 | 0 |
| Ending cash balance | 716.29M | 778.65M | 1.11B | 1.08B | 1.11B | 859.82M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.38 | 1.48 | -1.07 | -2.09 | 1.67 | 6.05 | 2.76 | 8.89 |
| ROA %i | 2.11 | 0.96 | -0.71 | -1.36 | 1.11 | 3.89 | 1.73 | 5.84 |
| ROIC %i | 3.32 | 1.90 | -0.31 | -0.84 | 1.78 | 4.55 | 3.14 | 8.45 |
| 5-year avg ROE %i | 0.56 | 0.17 | -0.28 | -0.47 | 0.67 | 1.21 | 1.46 | 3.46 |
| EBIT margin %i | 6.53 | 11.75 | 1.01 | -2.93 | 8.24 | 22.38 | 12.27 | 25.07 |
| FCF / sales %i | 29.27 | 24.25 | -- | 24.37 | 8.63 | 20.66 | 22.12 | 30.89 |
| Current ratioi | 2.38 | 6.51 | 6.40 | 5.18 | 5.92 | 1.55 | 1.62 | 2.47 |
| Quick ratioi | 1.74 | 5.05 | 3.87 | 3.96 | 4.46 | 0.84 | 0.80 | 1.52 |
| Debt / assetsi | 18.65 | 13.42 | 13.13 | 13.25 | 11.55 | 17.96 | 12.93 | 9.67 |
| LT debt / equityi | 19.95 | 19.96 | 20.08 | 20.56 | 17.08 | 21.07 | 15.64 | 14.43 |
| Interest coveragei | 1.41 | 2.61 | 0.32 | -0.71 | 2.23 | 6.29 | 3.00 | 9.12 |
| Revenue CAGR (3Y) %i | -8.77 | -8.49 | -5.85 | -10.99 | 0.09 | 12.86 | 28.58 | 23.07 |
| Net income CAGR (3Y) %i | 36.58 | -- | -- | -- | 6.50 | -- | -- | 87.54 |
| FCF CAGR (3Y) %i | 88.46 | 67.89 | -- | -16.26 | -29.08 | -- | 24.49 | 88.27 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 8.25 | 8.10 | 8.89 | 9.60 | 5.12 | 5.68 |
| ROA %i | 5.63 | 5.53 | 5.84 | 6.68 | 3.57 | 3.95 |
| ROIC %i | 7.84 | 7.70 | 8.45 | 9.02 | 5.05 | 5.55 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.35 | 21.94 | 25.07 | 25.72 | 16.21 | 17.30 |
| FCF / sales %i | 25.25 | 28.07 | 30.89 | 26.05 | 16.00 | 10.31 |
| Current ratioi | 2.96 | 2.99 | 2.47 | 3.08 | 3.06 | 2.55 |
| Quick ratioi | 1.75 | 1.57 | 1.52 | 1.84 | 1.87 | 1.36 |
| Debt / assetsi | 10.39 | 10.23 | 9.67 | 9.86 | 9.68 | 9.61 |
| LT debt / equityi | 14.77 | 14.69 | 14.43 | 14.11 | 13.97 | 13.78 |
| Interest coveragei | 7.66 | 7.94 | 9.12 | 9.79 | 6.11 | 6.53 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
WEC144.65%
Uranium83.67%
Fuel Services15.36%
Other0.97%
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Cameco discussion 0 comments